What is the recommended diagnostic workup and initial management for a patient presenting with hematochezia, diarrhea, abdominal pain, and weight loss?

Diagnostic Workup and Initial Management for Hematochezia, Diarrhea, Abdominal Pain, and Weight Loss

This constellation of symptoms—hematochezia, diarrhea, abdominal pain, and weight loss—strongly suggests inflammatory bowel disease (IBD), particularly Crohn's disease or ulcerative colitis, and requires urgent diagnostic evaluation with colonoscopy and comprehensive laboratory testing to confirm the diagnosis and exclude other serious pathology including colorectal cancer. 1, 2

Initial Clinical Assessment

History and Physical Examination

Obtain specific details about:

• Stool characteristics: frequency, consistency, presence of blood (mixed within stool vs. coating), urgency, tenesmus 2
• Constitutional symptoms: fever, malaise, anorexia (more common in Crohn's disease) 2
• Duration of symptoms: chronic diarrhea (>6 weeks) with weight loss raises IBD suspicion 1, 3
• Recent travel, medication use (NSAIDs), smoking status, and family history of IBD or colorectal cancer 2
• Extraintestinal manifestations: joint pain, skin lesions, eye symptoms 2

Physical examination must assess:

• Vital signs: pulse rate, blood pressure, temperature (four times daily if severe) 2
• Signs of dehydration or anemia 2
• Abdominal tenderness, distension, or palpable masses 2
• Perianal examination for fistulae or abscesses (suggests Crohn's disease) 2

Laboratory Investigations

Immediate laboratory workup should include: 2

• Complete blood count (hemoglobin <10 g/dL suggests severe disease) 2
• Serum albumin (hypoalbuminemia indicates severity) 2, 1
• Serum ferritin 1
• C-reactive protein (CRP) and/or erythrocyte sedimentation rate (ESR) 2, 1, 2
• Liver function tests, urea, and creatinine 1, 2
• Stool testing: Clostridium difficile toxin (mandatory in all new diarrhea presentations regardless of antibiotic history), culture, ova and parasites 1, 2
• Fecal calprotectin or lactoferrin to prioritize endoscopic evaluation (helps distinguish IBD from functional disorders) 1

Imaging Studies

Initial Imaging

• Abdominal radiography is essential to exclude colonic dilatation (transverse colon >5.5 cm) and assess disease extent 2
• CT enterography or CT abdomen/pelvis is appropriate for acute presentations, especially with prominent abdominal pain, to rule out complications (abscesses, strictures, perforation) and alternative diagnoses (ischemic colitis, diverticular disease, colorectal cancer) 1

Endoscopic Evaluation

Colonoscopy with ileoscopy and multiple biopsies is the cornerstone of diagnosis and should be performed urgently. 1, 2

Colonoscopy Approach

• For stable patients with intermediate-to-high IBD suspicion: proceed directly to colonoscopy with ileal intubation and biopsies from multiple sites (at least 2 biopsies from 5 sites including ileum and rectum) 2, 4, 2
• For severe presentations: flexible sigmoidoscopy may be safer than full colonoscopy to avoid perforation risk; defer complete examination until clinical improvement 4, 2
• Avoid bowel purgatives in severe colitis; flexible sigmoidoscopy without preparation is sufficient for diagnosis 4

Diagnostic Findings

• Ulcerative colitis: continuous inflammation starting from rectum, loss of vascular pattern, granularity, friability, ulceration 2
• Crohn's disease: focal, asymmetric inflammation, skip lesions, aphthous ulcers, cobblestone appearance, perianal lesions 2, 4

Alternative Diagnoses to Exclude

In elderly patients (>60 years), colonoscopy is critical to differentiate IBD from: 1

• Colorectal cancer
• Ischemic colitis (normal rectum, watershed territory involvement, rapid resolution)
• Segmental colitis associated with diverticulosis
• NSAID-induced pathology
• Microscopic colitis

Additional Diagnostic Considerations

If colonoscopy and imaging are negative but clinical suspicion for Crohn's disease remains high, proceed to video capsule endoscopy of the small bowel (diagnostic yield 50-72% for small bowel pathology). 3

Initial Management

Supportive Care (All Patients)

• Intravenous fluid and electrolyte replacement to correct dehydration 2, 5
• Blood transfusion to maintain hemoglobin >10 g/dL 2
• Subcutaneous low-molecular-weight heparin for thromboprophylaxis 2, 5
• Nutritional support (enteral or parenteral) if malnourished 2, 5

Medical Therapy Based on Severity

For Severe Ulcerative Colitis (Truelove and Witts' criteria)

• Admit for intensive intravenous therapy 2
• Intravenous corticosteroids (prednisolone 40 mg daily or equivalent methylprednisolone) immediately in hemodynamically stable patients 2, 5
• Assess response by day 3 using pulse rate, stool frequency, CRP, and abdominal radiography 2, 5
• If no response by day 3: consider medical rescue therapy with infliximab (5 mg/kg) combined with thiopurine, or ciclosporin in multidisciplinary approach 5
• Joint medical-surgical management from admission; inform patient of 25-30% colectomy risk 2

For Mild-Moderate Ulcerative Colitis

• Combination therapy: topical mesalazine or topical corticosteroids PLUS oral mesalazine or oral prednisolone 40 mg daily (more effective than monotherapy) 2
• Taper prednisolone gradually over 8 weeks according to response 2

For Crohn's Disease

• Antibiotics only if superinfection or intra-abdominal abscess present (not routine) 5
• For abscesses >3 cm: percutaneous drainage with empiric antibiotics (covering Gram-negative aerobes, Gram-positive streptococci, anaerobes) as bridging to elective surgery 5
• For abscesses <3 cm: empiric antimicrobial therapy with close monitoring 5
• Infliximab may be considered for penetrating ileocecal disease after adequate abscess resolution, in multidisciplinary approach 5

Critical Pitfalls to Avoid

• Do not delay corticosteroid treatment while awaiting stool microbiology results in suspected severe UC 2
• Do not use antibiotics routinely in IBD without evidence of superinfection 5
• Do not perform colonoscopy in severe colitis without surgical consultation available; use flexible sigmoidoscopy instead 4, 2
• Do not miss C. difficile testing in all diarrhea presentations, as superinfection accounts for significant IBD flares 1, 4